The adhesion molecule CD44 is a cell surface type 1 hyaluronan transmembrane glycoprotein receptor, and the inhibition of CD44 signaling has been found to be beneficial for the treatment of tumor patients [5]. This evidence concerns the gene CD44 and neoplasm.